We are calling on the government to make HIV pre-exposure prophylaxis (PrEP) available for those individuals at highest risk of HIV infection.
What is PrEP?
Research suggests that PrEP is as effective as condoms in preventing HIV transmission, as long as the pills are taken regularly, as directed. PrEP is an effective and economic way to prevent the spread of HIV.
Two European studies of PrEP reported early results in October 2014. Both studies showed that PrEP was so effective at preventing HIV transmission that everyone in these studies has now been offered PrEP.
More information about PrEP research.
The World Health Organisation (WHO) has recommended that PrEP should be made available immediately for those men who have sex with men (MSM) at greatest risk.
More about how PrEP works and how to access it.
Why we're calling for PrEP to be made available in England
We welcome the news that PrEP will be made available to 10,000 people in England, but there are many questions to be answered about the trial.
There continue to be high rates of new HIV infections and as PrEP has been proven to be effective, NHS England urgently needs to find a way to make PrEP available to everyone who needs it and not solely through a trial. Interim arrangements need to be agreed now for the provision of PrEP in England to those at the highest risk of acquiring HIV.
Read our response to NHS England's decision to scrap plans for PrEP.
Download our full briefing on PrEP [PDF]
PrEP in Scotland
In April 2017, Scotland became the first country in the UK to approve PrEP to all those at risk on NHS Scotland and this is to be rolled out across the country in July 2017. We are working with other HIV organisations such as HIV Scotland to ensure that when PrEP is rolled out, there aren’t any postcode lotteries and that all local health boards provide PrEP to those who need it.
PrEP in Wales
In April 2017, the government in Wales decided to implement a pilot on PrEP, similar to the trial in England. We sit on the steering group established for that pilot, which is due to be implemented on 17 July 2017. All those for whom the drug is clinically appropriate can access it and more information is due to be released shortly on how to access PrEP through the pilot, which will run for three years.
Join our campaign for access to PrEP in the UK by using the hashtag #WhereisPrEP.
We campaign on this issue as part of United4PrEP, a coalition of nearly one hundred organisations and individuals.